PF 610355
/ Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 10, 2011
A study to investigate the safety, toleration and efficacy of PF00610355 in chronic obstructive pulmonary disease (COPD) patients (A7881013)
(clinicaltrials.gov)
- P2, N=405; N=380→405; Active, not recruiting→Completed; Start date: Mar '09→ Mar '10
Enrollment • Start date • Trial completion • Asthma
1 to 1
Of
1
Go to page
1